Neurosurgery News and Research RSS Feed - Neurosurgery News and Research

Elekta's Flexitron brachytherapy afterloading platform approved in China

Elekta's Flexitron brachytherapy afterloading platform approved in China

Elekta announces that the China Food and Drug Administration has approved Elekta's Flexitron brachytherapy afterloading platform for sale and marketing in China. [More]
SPECT scan measures brain activity during seizures

SPECT scan measures brain activity during seizures

Loyola University Medical Center is offering epileptic patients an imaging scan that records brain activity during seizures. [More]
Intra-arterial stroke treatment more effective than medical management with tPA, study finds

Intra-arterial stroke treatment more effective than medical management with tPA, study finds

Penumbra, Inc., the market leader in intra-arterial stroke treatment, announced that an independent study published online today in the New England Journal of Medicine found that intra-arterial stroke treatment, including the company's clot extraction technology, was shown to be significantly more effective than medical management with tissue plasminogen activator (tPA), which is the current standard of care. [More]
Study finds increasing shortage of stroke specialists in the U.S.

Study finds increasing shortage of stroke specialists in the U.S.

Although stroke is the No. 4 cause of death and a leading cause of disability in the United States, there's an increasing shortage of neurologists who specialize in stroke care. [More]
Researchers develop new eye tracking technology that can assess impact of brain injury

Researchers develop new eye tracking technology that can assess impact of brain injury

Researchers at NYU Langone Medical Center have developed new technology that can assess the location and impact of a brain injury merely by tracking the eye movements of patients as they watch music videos for less than four minutes, according to a study published Friday on-line in the Journal of Neurosurgery. [More]
Researchers find that one in six Ontario adults reports a history of TBI

Researchers find that one in six Ontario adults reports a history of TBI

Nearly seventeen per cent of adults surveyed in Ontario said they have suffered a traumatic brain injury that left them unconscious for five minutes or required them to be hospitalized overnight, according to new research. These same adults also reported more substance use, smoking and recent psychiatric distress. [More]
Study reveals how the human brain heals itself after surgical removal of brain tumor

Study reveals how the human brain heals itself after surgical removal of brain tumor

An interdisciplinary team of neuroscientists and neurosurgeons from the University of Rochester has used a new imaging technique to show how the human brain heals itself in just a few weeks following surgical removal of a brain tumor. [More]
Progesterone treatment shows no clinical benefits in severe TBI patients

Progesterone treatment shows no clinical benefits in severe TBI patients

A study concluded that after five days of treatment with a novel formulation of progesterone acutely administered to patients with severe traumatic brain injury (TBI), showed no clinical benefits. [More]
Golden Jubilee National Hospital first to use revolutionary technology in rib fracture surgery

Golden Jubilee National Hospital first to use revolutionary technology in rib fracture surgery

The Golden Jubilee National Hospital recently became the first hospital in Scotland to use a revolutionary new technology on a patient suffering from a severe rib fracture. [More]
Fiagon's ENT Extended Instrument Set receives FDA approval

Fiagon's ENT Extended Instrument Set receives FDA approval

Fiagon AG medical technologies announced today that it received U.S. Food and Drug Administration 510(k) clearance for its ear, nose and throat (ENT) Extended Instrument Set. The clearance includes the company's tip-navigated GuideWire, PointerShell instrument adaptor and FlexTube navigated suction and irrigation. [More]
Northwestern Medicine neurosurgeons use new adaptive hybrid surgery technology to treat brain tumor

Northwestern Medicine neurosurgeons use new adaptive hybrid surgery technology to treat brain tumor

It started with numbness on the left side of his face. A few months later, Steve Mores couldn't feel his tongue or chew on the left side of his mouth. TV commercials featuring food or even being in a grocery store made him nauseous. A long time drummer in a popular band, Mores lost 30 pounds and had to find a replacement. [More]
Monash Vision Group moves a step closer to Bionic Eye clinical trials

Monash Vision Group moves a step closer to Bionic Eye clinical trials

The Monash Vision Groupmoves a step closer to clinical trials of its Bionic Eye, thanks to landmark donations from two respected business leaders. [More]
Real-time surgical guidance study to evaluate TriVersa NanoMate with LESA capability from Advion

Real-time surgical guidance study to evaluate TriVersa NanoMate with LESA capability from Advion

Advion, Inc. announces that is its TriVersa NanoMate with liquid extraction surface analysis (LESA) capability will be evaluated as part of a study at Brigham and Women’s Hospital. [More]

Alim Louis Benabid, Mahlon DeLong jointly win 2014 Lasker-DeBakey Clinical Medical Research Award

French neurosurgeon Alim Louis Benabid and American neurologist Mahlon DeLong were recently named winners of the 2014 Lasker-DeBakey Clinical Medical Research Award for their roles in developing deep brain stimulation (DBS) for the treatment of Parkinson disease. [More]
'Safe entry zones' for neurosurgeons who perform brainstem surgery

'Safe entry zones' for neurosurgeons who perform brainstem surgery

A study using intricate fiber dissection techniques provides new insights into the deep anatomy of the human brainstem--and helps to define "safe entry zones" for neurosurgeons performing brainstem surgery, according to a special article published in Operative Neurosurgery, a quarterly supplement to Neurosurgery, official journal of the Congress of Neurological Surgeons. [More]

IMRIS successfully completes human factors study for SYMBIS Surgical System

IMRIS Inc. today announced that the Company has successfully completed the human factors study for the SYMBIS Surgical System – the comprehensive validation used to support the product's 510(k) submission to the U.S. Food and Drug Administration on November 26. [More]
Sanovas's endoscopic imaging platform recognized by Frost & Sullivan

Sanovas's endoscopic imaging platform recognized by Frost & Sullivan

Based on its recent analysis of the endoscopic imaging market, Frost & Sullivan recognizes Sanovas Inc. with the 2014 Global Frost & Sullivan Award for New Product Innovation Leadership. In a market where spiralling healthcare costs impact the entire spectrum of stakeholders, Sanovas's ground-breaking endoscopic platform, MicroCam, provides the functionality of a high-end, flexible endoscope without the accompanying cost and maintenance burden. [More]
PET/CT may improve differentiation of PTSD from MTBI

PET/CT may improve differentiation of PTSD from MTBI

Hybrid imaging with positron emission tomography and computed tomography (PET/CT) in the pituitary region of the brain is a promising tool for differentiating military veterans with post-traumatic stress disorder (PTSD) from those with mild traumatic brain injury (MTBI), according to a new study presented at the annual meeting of the Radiological Society of North America (RSNA). [More]
Good Samaritan Hospital receives $417,560 grant to implement telemedicine program

Good Samaritan Hospital receives $417,560 grant to implement telemedicine program

The U.S. Department of Agriculture (USDA) Rural Development awards Good Samaritan Hospital, a prominent downtown Los Angeles hospital, a $417,560 grant to implement a telemedicine program that will connect members of the medical staff at Good Samaritan Hospital with public health and primary care providers and their patients at six Public Health sites on the island of Guam. [More]
GABA injections prevent and reverse Type 1 diabetes in mice

GABA injections prevent and reverse Type 1 diabetes in mice

A chemical produced in the pancreas that prevented and even reversed Type 1 diabetes in mice had the same effect on human beta cells transplanted into mice, new research has found. [More]